Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Sep 02 2021

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 02, 2021, titled "Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market.".

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases